253 related articles for article (PubMed ID: 27879211)
1. Generation of a human induced pluripotent stem cell (iPSC) line from a patient carrying a P33T mutation in the PDX1 gene.
Wang X; Chen S; Burtscher I; Sterr M; Hieronimus A; Machicao F; Staiger H; Häring HU; Lederer G; Meitinger T; Lickert H
Stem Cell Res; 2016 Sep; 17(2):273-276. PubMed ID: 27879211
[TBL] [Abstract][Full Text] [Related]
2. Generation of a human induced pluripotent stem cell (iPSC) line from a patient with family history of diabetes carrying a C18R mutation in the PDX1 gene.
Wang X; Chen S; Burtscher I; Sterr M; Hieronimus A; Machicao F; Staiger H; Häring HU; Lederer G; Meitinger T; Lickert H
Stem Cell Res; 2016 Sep; 17(2):292-295. PubMed ID: 27879214
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide analysis of PDX1 target genes in human pancreatic progenitors.
Wang X; Sterr M; Burtscher I; Chen S; Hieronimus A; Machicao F; Staiger H; Häring HU; Lederer G; Meitinger T; Cernilogar FM; Schotta G; Irmler M; Beckers J; Hrabě de Angelis M; Ray M; Wright CVE; Bakhti M; Lickert H
Mol Metab; 2018 Mar; 9():57-68. PubMed ID: 29396371
[TBL] [Abstract][Full Text] [Related]
4. Point mutations in the PDX1 transactivation domain impair human β-cell development and function.
Wang X; Sterr M; Ansarullah ; Burtscher I; Böttcher A; Beckenbauer J; Siehler J; Meitinger T; Häring HU; Staiger H; Cernilogar FM; Schotta G; Irmler M; Beckers J; Wright CVE; Bakhti M; Lickert H
Mol Metab; 2019 Jun; 24():80-97. PubMed ID: 30930126
[TBL] [Abstract][Full Text] [Related]
5. Generation of a gene-corrected isogenic control cell line from an Alzheimer's disease patient iPSC line carrying a A79V mutation in PSEN1.
Pires C; Schmid B; Petræus C; Poon A; Nimsanor N; Nielsen TT; Waldemar G; Hjermind LE; Nielsen JE; Hyttel P; Freude KK
Stem Cell Res; 2016 Sep; 17(2):285-288. PubMed ID: 27879212
[TBL] [Abstract][Full Text] [Related]
6. Generation of induced pluripotent stem cells (iPSCs) from a retinoblastoma patient carrying a c.2663G>A mutation in RB1 gene.
Zeng S; Liu L; Ouyang Q; Zhao Y; Lin G; Hu L; Li W
Stem Cell Res; 2016 Sep; 17(2):208-211. PubMed ID: 27879208
[TBL] [Abstract][Full Text] [Related]
7. Generation of human iPSCs from an essential thrombocythemia patient carrying a V501L mutation in the MPL gene.
Liu S; Ye Z; Gao Y; He C; Williams DW; Moliterno A; Spivak J; Huang H; Cheng L
Stem Cell Res; 2017 Jan; 18():57-59. PubMed ID: 28395806
[TBL] [Abstract][Full Text] [Related]
8. Generation of a human iPSC line from a patient with a defect of intergenomic communication.
Zurita F; Galera T; González-Páramos C; Moreno-Izquierdo A; Schneiderat P; Fraga MF; Fernández AF; Garesse R; Gallardo ME
Stem Cell Res; 2016 Jan; 16(1):120-3. PubMed ID: 27345795
[TBL] [Abstract][Full Text] [Related]
9. Generation of an iPSC line from a patient with GTP cyclohydrolase 1 (GCH1) deficiency: HDMC0061i-GCH1.
Jung-Klawitter S; Ebersold J; Göhring G; Blau N; Opladen T
Stem Cell Res; 2017 Apr; 20():38-41. PubMed ID: 28395739
[TBL] [Abstract][Full Text] [Related]
10. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying a L150P mutation in PSEN-1.
Tubsuwan A; Pires C; Rasmussen MA; Schmid B; Nielsen JE; Hjermind LE; Hall V; Nielsen TT; Waldemar G; Hyttel P; Clausen C; Kitiyanant N; Freude KK; Holst B
Stem Cell Res; 2016 Jan; 16(1):110-2. PubMed ID: 27345792
[TBL] [Abstract][Full Text] [Related]
11. Generation of a human iPSC line from a patient with an optic atrophy 'plus' phenotype due to a mutation in the OPA1 gene.
Galera-Monge T; Zurita-Díaz F; Moreno-Izquierdo A; Fraga MF; Fernández AF; Ayuso C; Garesse R; Gallardo ME
Stem Cell Res; 2016 May; 16(3):673-6. PubMed ID: 27346197
[TBL] [Abstract][Full Text] [Related]
12. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying an A79V mutation in PSEN1.
Li T; Pires C; Nielsen TT; Waldemar G; Hjermind LE; Nielsen JE; Dinnyes A; Hyttel P; Freude KK
Stem Cell Res; 2016 Mar; 16(2):229-32. PubMed ID: 27345973
[TBL] [Abstract][Full Text] [Related]
13. Generation of an iPSC line from a patient with tyrosine hydroxylase (TH) deficiency: TH-1 iPSC.
Jung-Klawitter S; Blau N; Sebe A; Ebersold J; Göhring G; Opladen T
Stem Cell Res; 2016 Nov; 17(3):580-583. PubMed ID: 27934587
[TBL] [Abstract][Full Text] [Related]
14. Generation of a human iPSC line from a patient with a mitochondrial encephalopathy due to mutations in the GFM1 gene.
Zurita-Díaz F; Galera-Monge T; Moreno-Izquierdo A; Fraga MF; Ayuso C; Fernández AF; Garesse R; Gallardo ME
Stem Cell Res; 2016 Jan; 16(1):124-7. PubMed ID: 27345796
[TBL] [Abstract][Full Text] [Related]
15. Induced pluripotent stem cells (iPSCs) derived from cerebrotendinous xanthomatosis (CTX) patient's fibroblasts carrying a R395S mutation.
Höflinger P; Hauser S; Theurer Y; Weißenberger S; Wilke C; Schöls L
Stem Cell Res; 2016 Sep; 17(2):433-436. PubMed ID: 27879219
[TBL] [Abstract][Full Text] [Related]
16. Generation of a disease-specific iPS cell line derived from a patient with Charcot-Marie-Tooth type 2K lacking functional GDAP1 gene.
Martí S; León M; Orellana C; Prieto J; Ponsoda X; López-García C; Vílchez JJ; Sevilla T; Torres J
Stem Cell Res; 2017 Jan; 18():1-4. PubMed ID: 28395795
[TBL] [Abstract][Full Text] [Related]
17. Induced pluripotent stem cells (iPSCs) derived from a symptomatic carrier of a S305I mutation in the microtubule-associated protein tau (MAPT)-gene causing frontotemporal dementia.
Nimsanor N; Jørring I; Rasmussen MA; Clausen C; Mau-Holzmann UA; Kitiyanant N; Nielsen JE; Nielsen TT; Hyttel P; Holst B; Schmid B
Stem Cell Res; 2016 Nov; 17(3):564-567. PubMed ID: 27789411
[TBL] [Abstract][Full Text] [Related]
18. Generation of human iPSCs from urine derived cells of a patient with a novel homozygous PAI-1 mutation.
Afzal MZ; Gartz M; Klyachko EA; Khan SS; Shah SJ; Gupta S; Shapiro AD; Vaughan DE; Strande JL
Stem Cell Res; 2016 Nov; 17(3):657-660. PubMed ID: 27934602
[TBL] [Abstract][Full Text] [Related]
19. Generation of induced pluripotent stem cells (iPSCs) from a hereditary spastic paraplegia patient carrying a homozygous Y275X mutation in CYP7B1 (SPG5).
Hauser S; Höflinger P; Theurer Y; Rattay TW; Schöls L
Stem Cell Res; 2016 Sep; 17(2):437-440. PubMed ID: 27879220
[TBL] [Abstract][Full Text] [Related]
20. Peripheral blood derived induced pluripotent stem cells (iPSCs) from a female with familial hypertrophic cardiomyopathy.
Ross SB; Fraser ST; Bagnall RD; Semsarian C
Stem Cell Res; 2017 Apr; 20():76-79. PubMed ID: 28395744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
